Sfoglia per AUTORE
VIGNETTI M
Collezione ASL Asti

  

Items : 6

Health-Related Quality of Life and Symptom Burden Profile of Patients with Pre-Fibrotic and Overt Myelofibrosis: A Preliminary Report from the Gimema-Prophecy Observational Study in Blood

2023
ASL Asti

Caocci G; Palandri F; Loscocco GG; Tieghi A; Patriarca A; Iurlo A; Abruzzese E; Rossi E; Baldi T; Fava C; Beggiato E; Tomasetti S; Marchetti M; Vanni D; Fozza C; Luppi M; La Nasa G; Fazi P; Vignetti M; Vannucchi AM; Efficace F;

Health-Related Quality of Life of Patients with Philadelphia-Negative Myeloproliferative Neoplasms Compared with the General Population: A Preliminary Report from the Gimema Prophecy Study in Blood

2022
ASL Asti

Caocci G; Palandri F; Loscocco GG; Piciocchi A; Iurlo A; Tieghi A; Patriarca A; Abruzzese E; Tomassetti S; Marchetti M; Vanni D; Luppi M; Pane F; Breccia M; Siragusa S; Elli EM; Ricco A; Fozza C; Corsetti MT; Fava C; Mazzoni C; Fazi P; La Nasa G; Vignetti M; Vannucchi AM; Efficace F;

Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group. in Hematological oncology / Hematol Oncol. 2021 Aug;39(3):326-335. doi: 10.1002/hon.2861. Epub 2021 Mar 26.

2021
ASL Asti
AOU Città della Salute di Torino
AOU Novara

Foà R; Cuneo A; Vignetti M; Gentile M; Montillo M; Marchetti M; Mauro FR; Crea E; Marasca R; Quaglia FM; Laurenti L; Molinari AL; Paolini R; Pietrasanta D; Sportoletti P; Varettoni M; Farina L; Murru R; Gaidano G; Cibien F; Vitagliano O; Coscia M; Zamprogna G; Visentin A; Reda G; Arena V; Cavazzini F; Piciocchi A; Rigolin GM; et alii...

Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study. in Cancer medicine / Cancer Med. 2020 Nov;9(22):8468-8479. doi: 10.1002/cam4.3470. Epub 2020 Sep 24.

2020
ASL Asti
AOU Città della Salute di Torino

Foà R; Ghia P; Cucci R; Vignetti M; Cavallari M; Cimino G; Ferrarini I; de la Serna J; Medina Perez A; Mauro FR; Di Raimondo F; Coscia M; Molica S; Farina L; Doubek M; Gaidano G; Ilariucci F; Marchetti M; Tedeschi A; Spacek M; Trentin L; Billio A; Roeker L; Orlandi EM; Ujjani CS; Shah NN; Sehgal AR; Schuster SJ; Pu JJ; et alii...

Complex Karyotype Is Associated with A Less Favorable Outcome after Ibrutinib and Rituximab As Front-Line Treatment of Unfit Patients with Chronic Lymphocytic Leukemia (GIMEMA LLC1114) in Haematologica

2020
ASL Asti

Del Giudice I; Rigolin GM; Bardi A; Melandri A; Cavallari M; Raponi S; Ilari C; Cafforio L; Piciocchi A; Arena V; Fabri S; Albano F; Nanni M; Molica S; Reda G; Sportoletti M; Trentin L; Marchetti M; Peragine N; Mariglia P; Vignetti M; Mauro FR; Guarini A; Foà R; Cuneo A;

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study. in Haematologica / Haematologica. 2018 Jul;103(7):1209-1217. doi: 10.3324/haematol.2018.189837. Epub 2018 Apr 19.

2018
ASL Asti
AOU Città della Salute di Torino
AOU Novara

Ghia P; Moreno C; Foà R; de la Serna J; Vignetti M; Kennedy B; Bowles KM; Eyre TA; Schuh A; Smolej L; Montillo M; Cortelezzi A; Ciolli S; Forconi F; Gonzalez M; Gaidano G; Re F; Molica S; Marchetti M; Ilariucci F; Meneghini V; Chiarenza A; Marasca R; Billio A; Visco C; Amendola A; Mauro FR; Galieni P; Orlandi EM; et alii...